Literature DB >> 4344252

Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2.

W Gibson, B Roizman.   

Abstract

Two classes of herpesvirus capsids, designated A and B, were isolated from the nuclei of human cells infected with herpes simplex virus (HSV). A and B capsids share in common four structural proteins, i.e., no. 5, 19, 23, and 24. B capsids contain 7.7 to 9.7 times more deoxyribonucleic acid than A capsids; moreover, they contain proteins no. 21 and 22a in addition. All of the proteins contained in the capsid except no. 22a are present in the enveloped nucleocapsids (virions) in approximately the same molar ratios. The capsid proteins of HSV-1 cannot be differentiated from their HSV-2 counterparts with respect to electrophoretic mobility. A third class of capsids, designated C capsids, was isolated from virions contained in the cytoplasm of infected cells by the same procedure used to obtain A and B capsids. The C capsids contain all of the proteins present in A capsids plus proteins 1 to 3 and 21.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344252      PMCID: PMC356576     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  [Comparative studies of quantitative determination of proteins in cerebrospinal fluid and low-protein solutions].

Authors:  M EGGSTEIN; F H KREUTZ
Journal:  Klin Wochenschr       Date:  1955-10-01

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Herpes simplex virus structural proteins.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

5.  Herpesvirus envelopment.

Authors:  R W Darlington; L H Moss
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

6.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Synthesis of proteins in cells infected with herpesvirus, VI. Characterization of the proteins of the viral membrane.

Authors:  A S Kaplan; T Ben-Porat
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

9.  Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2.

Authors:  E D Kieff; S L Bachenheimer; B Roizman
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

10.  Electron microscopic observations on the development of herpes simplex virus.

Authors:  C MORGAN; H M ROSE; M HOLDEN; E P JONES
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307

View more
  193 in total

1.  Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.

Authors:  K Nealon; W W Newcomb; T R Pray; C S Craik; J C Brown; D H Kedes
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells.

Authors:  P J Desai
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions.

Authors:  M T Sciortino; M Suzuki; B Taddeo; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Intracellular Cre-mediated deletion of the unique packaging signal carried by a herpes simplex virus type 1 recombinant and its relationship to the cleavage-packaging process.

Authors:  C Logvinoff; A L Epstein
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids.

Authors:  Prashant Desai; Jean-Claude Akpa; Stanley Person
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  The herpes simplex virus 1 UL17 protein is the second constituent of the capsid vertex-specific component required for DNA packaging and retention.

Authors:  Katerina Toropova; Jamie B Huffman; Fred L Homa; James F Conway
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

7.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  The capsid and tegument of the alphaherpesviruses are linked by an interaction between the UL25 and VP1/2 proteins.

Authors:  Kelly Elizabeth Coller; Joy I-Hsuan Lee; Aki Ueda; Gregory Allan Smith
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Release of the catalytic domain N(o) from the herpes simplex virus type 1 protease is required for viral growth.

Authors:  L Matusick-Kumar; P J McCann; B J Robertson; W W Newcomb; J C Brown; M Gao
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  The bovine herpesvirus 1 maturational proteinase and scaffold proteins can substitute for the homologous herpes simplex virus type 1 proteins in the formation of hybrid type B capsids.

Authors:  E J Haanes; D R Thomsen; S Martin; F L Homa; D E Lowery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.